mitomycin

Poland

Drugs containing this active substance

  • MITOMYCIN ACCORD

    The medicine is used in the treatment of malignant tumors to alleviate their symptoms. It may be administered intravenously (e.g., in the case of stomach, breast, pancreatic, or lung cancer) or into the bladder to prevent the recurrence of superficial bladder cancer.

    Form: powder for preparation of solution for injection / infusion or for bladder

    Active substance Dosage
    mitomycin 10 mg

    ATC: L01DC03

    Manufacturer: Accord Healthcare Polska Sp. z o.o.

  • The medicinal product is used in the treatment of malignant tumors to relieve symptoms (palliative treatment). It may be administered intravenously in the case of gastric, breast, pancreatic, and lung cancer, and may also be administered into the bladder to prevent the recurrence of superficial bladder cancer.

    Form: powder for preparation of solution for injection / infusion or for bladder

    Active substance Dosage
    mitomycin 20 mg

    ATC: L01DC03

    Manufacturer: Accord Healthcare Polska Sp. z o.o.

  • The medicine is used in the treatment of malignant tumors to relieve their symptoms (palliative treatment). It shows activity, among others, in cases of advanced stomach, breast, and pancreatic cancer, as well as respiratory tract cancer.

    Form: powder for preparation of solution for injection / infusion

    Active substance Dosage
    mitomycin 40 mg

    ATC: L01DC03

    Manufacturer: Accord Healthcare Polska Sp. z o.o.